Recent News

• 09.16.2025 - Q3 Investor Summit Group Virtual Conference
• 09.11.2025 - Making proteoforms mainstream with the Consortium for Top-Down Proteomics
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.04.2025 - Functional differences in the KRAS proteoform landscape
• 08.28.2025 - Benefits and needs of proteomics science communication
• 08.27.2025 - Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
• 08.21.2025 - Life at Nautilus Interview with Nicole Newland – Senior HR Operations Generalist
• 08.07.2025 - Excitement for Iterative Mapping of proteoforms at AAIC 2025
• 08.05.2025 - Insights from Iterative Mapping of tau proteoforms – bioRxiv preprint round up

Recent Filings

• 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.31.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2025 - 8-K Current report
• 07.31.2025 - EX-99.1 EX-99.1